MEX3D and non-small cell lung carcinoma: Therefore, we investigated a large sample of databases to explore MEX3 family expression, prognostic value, and immune-related effects in non-small-cell lung cancer (NSCLC), thereby providing further insights into tumour heterogeneity and as potential targets for immunotherapy [12, 20, 21].